Document is current

Article History

Received: 3 October 2024

Accepted: 4 April 2025

First Online: 23 April 2025

Declarations

:

: Ethical approval was granted by the ethics committee of the Baden-Württemberg Federal Chamber of Physicians (Sign F-2018-059). The study was conducted in accordance with the Declaration of Helsinki. All enrolled participants provided their voluntary and informed written consent to participate in the study.

: Not applicable.

: VH declares that she has recently been employed by LIME medical, which was not involved in the study at any time. AT has received honoraria for online lectures and talks from Pflaum Verlag, Messe Karlsruhe, and ZTM Bad Kissingen GmbH. None resulted in a conflict of interest. PF has received speaker’s fees and honoraria for advisory boards from Almirall, Bayer, Biogen Idec, BMS-Celgene, Coloplast, Genzyme, GW Pharma, Hexal, Janssen-Cilag, Novartis, Merck, Roche, Sanofi, Stadapharm and Teva. None resulted in a conflict of interest. MM has received compensation for lectures, consulting and travel expenses from Almirall, Alexion, Argenex, Biogen, BMS, CSL Behring, Hexal, Genzyme, Jansen, GSK, Merck, Novartis, Roche, Sanofi, Teva, UCB, and Viatris. None resulted in a conflict of interest. RS declares that he is currently an employee of the German Association for Health Sports and Sports Therapy (DVGS e.V.). This is a non-profit association for exercise therapy and physical activity promotion. CD has received speaker’s fees from Novartis and Sanofi. None resulted in a conflict of interest. HR has received honoraria for lectures and advisory boards from Novartis, Merck Serono, Biogen Idec, BMS-Celgene, Hexal Neuraxpharm, and Roche. None resulted in a conflict of interest. AS has received honoraria for lectures and for advisory boards from the following companies: Biogen, Merck, Novartis, Roche, and Sanofi. None resulted in a conflict of interest. HT has participated in meetings sponsored by or received honoraria for acting as an advisor/speaker for Alexion, Bayer, Biogen, Bristol-Myers Squibb, Celgene, Diamed, Fresenius, Fujirebio, GlaxoSmithKline, Horizon, Janssen-Cilag, Merck, Novartis, Roche, Sanofi-Genzyme, Siemens, and Teva. He also acknowledges research support by DMSG (German Multiple Sclerosis Society), MWK-BW (Ministry of Science, Research and Arts of the State Baden-Württemberg), University of Ulm, and Chemische Fabrik Karl Bucher. None resulted in a conflict of interest. PW, AR, LS, GH, SW, and KP declare no conflicts of interest.